Think Positive
Gerald stated that the LymPro partnership and the up-listing are still "on track" and that nothing has changed.
What if the partner for LymPro is a company such as Johnson & Johnson or Quest Diagnostics who is asking for an ownership position and a seat or two on the board of directors. Suppose they purchase 50,000,000 shares at .50 share as the basis for an "up-front cash payment" of $25,000,000.
Obviously the numbers could be different but this scenario makes perfect sense.
In regards to increasing the share count to have additional shares available one approach is "it's better to have them and not need them than to need them and not have them". To a small cap company such as $AMBS additional shares are similar to having a line of credit.
Monday will be interesting. Let's see what Gerald has to say.
Nothing more to say until after I read Gerald's blog.
Have a great weekend!!!
Twitter: @AmarantusBio .... 10,000+ followers.
Market Data 
Markets 
AI
